Splenectomy – diagnostic and therapeutic option in haematological disorders
Romanian Medical Journal · 2015
DOI: 10.37897/rmj.2015.1.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Medical Journal, 2015. Verfasst von Adriana Nica und 3 weiteren Autor:innen.
Abstract (Originalsprache)
For hematologic disorders, splenectomy has a wide range of applications: diagnosis, palliative or curative. The most frequent indication is for red cell disorders: hereditary spherocytosis, autoimmune hemolytic anemia or thalassemia. For the platelet disorders, the greatest benefit is achieved in idiopathic thrombocytopenic purpura. In case of limfoproliferative disorders (leukemia, lymphoma), splenectomy plays a role in diagnosis, palliative care (lowering of tumor burden) and in some cases as a cure. In patients with hematologic disorders, splenectomy is associated with an elevated risk of infections that can be avoided with proper antibiotic prophylaxis and vaccination. Due to the expanding list of applications for splenectomy in hematologic disorder, it is necessary to establish a work protocol that covers all aspects and particularities of these disorders.
Zitieren
APA
Nica, A., Vlădăreanu, A. M., Dumitru, I., & Onisâi, M. (2015). Splenectomy – diagnostic and therapeutic option in haematological disorders. Romanian Medical Journal. https://doi.org/10.37897/rmj.2015.1.6
Vancouver
Nica A, Vlădăreanu AM, Dumitru I, Onisâi M. Splenectomy – diagnostic and therapeutic option in haematological disorders. Romanian Medical Journal. 2015. doi:10.37897/rmj.2015.1.6
BibTeX
@article{Nica2015,
author = {Nica, Adriana and Vlădăreanu, Ana Maria and Dumitru, Ion and Onisâi, Minodora},
title = {Splenectomy – diagnostic and therapeutic option in haematological disorders},
journal = {Romanian Medical Journal},
year = {2015},
doi = {10.37897/rmj.2015.1.6}
}
EUVIMED